TY - JOUR AU - Farooq, Hamzah AU - Cirillo, Daniela AU - Hillemann, Doris AU - Wyllie, David AU - van der Werf, Marieke AU - Ködmön, Csaba AU - Nikolayevskyy, Vlad T1 - Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs T2 - Emerging Infectious Disease journal PY - 2021 VL - 27 IS - 3 SN - 1080-6059 AB - We surveyed availability of phenotypic drug susceptibility testing for drug-resistant Mycobacterium tuberculosis in Europe. Of 27 laboratories, 17 tested for linezolid, 11 for clofazimine, 9 for bedaquiline, and 6 for delamanid during 2019. Our findings indicate that testing capacity for newer and repurposed tuberculosis drugs exists, but its availability is limited. KW - Mycobacterium tuberculosis KW - bacteria KW - tuberculosis and other mycobacteria KW - tuberculosis KW - antimicrobial resistance KW - drug susceptibility KW - drugs KW - testing KW - public health KW - respiratory infections KW - Europe DO - 10.3201/eid2703.204418 UR - https://wwwnc.cdc.gov/eid/article/27/3/20-4418_article ER - End of Reference